Coronavirus vaccine formulations
US10953089B1 · kind B1 · utility
35Cited by
15References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2020 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Aug 19, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are coronavirus Spike (S) proteins and nanoparticles comprising the same, which are suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.